Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
25.88
+0.83 (3.31%)
Aug 31, 2026, 3:00 PM CST
SHA:600566 Market Cap
SHA:600566 has a market cap or net worth of 23.09 billion as of August 31, 2026. Its market cap has decreased by -3.40% in one year.
Market Cap
23.09B
Enterprise Value
12.78B
Revenue
5.80B
Ranking
n/a
PE Ratio
12.52
Stock Price
25.88
ChartMarket Cap Chart
Since December 24, 2013, SHA:600566's market cap has increased from 2.74B to 23.09B, an increase of 743.31%. That is a compound annual growth rate of 18.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 23.09B | -4.71% |
| Dec 31, 2025 | 24.23B | -9.61% |
| Dec 31, 2024 | 26.80B | -7.49% |
| Dec 29, 2023 | 28.97B | 15.46% |
| Dec 30, 2022 | 25.09B | -0.32% |
| Dec 31, 2021 | 25.17B | 40.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Walvax Biotechnology | 24.92B |
| Zhejiang Huahai Pharmaceutical | 24.80B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.15B |
| Apeloa Pharmaceutical Co.,Ltd | 24.01B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.37B |
| Guangdong Zhongsheng Pharmaceutical | 22.18B |
| Tasly Pharmaceutical Group | 22.14B |
| Harbin Pharmaceutical Group | 22.04B |